A new generation of weight-loss drugs is getting closer to patients. Here’s how they differ from Wegovy and Zepbound.

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

Lilly pill helps maintain weight loss in trial after switch from popular injections

Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

I Got Thin on a Weight-Loss Drug. I Wasn’t Ready for What Happened Next

I used to spend about 60% of each day thinking about food—when was the next meal? What was I going to eat? Would it be ...

Researchers Are Studying Medications That May Help Preserve Muscle During Weight Loss

The other experimental drug is bimagrumab, which is designed to help patients on weight loss medications from losing too much ...
STAT

Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow

Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
Woman's World on MSN

New weight loss drug beats Ozempic and eases joint pain with 'insane' results, doctors say

The average participant getting a 12-mg weekly injection lost 71 pounds in 68 weeks.  "This is beyond what we see with any ...
MPR

Oral Orforglipron Maintains Weight Loss After Switch From Injectable Therapies

According to Lilly, a New Drug Application for orforglipron for the treatment of adults with obesity or overweight has been submitted to the Food and Drug Administration.

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturingIn ...